iShares Neuroscience and Healthcare ETF (IBRN) Short Interest Ratio & Short Volume

Short interest is the volume of iShares Neuroscience and Healthcare ETF shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 1,500 shares of IBRN short. 1.00% of iShares Neuroscience and Healthcare ETF's shares are currently sold short. Learn More on iShares Neuroscience and Healthcare ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IBRN shares currently have a short interest ratio of 1.0. Learn More on iShares Neuroscience and Healthcare ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.00% of iShares Neuroscience and Healthcare ETF's floating shares are currently sold short.

iShares Neuroscience and Healthcare ETF saw a drop in short interest in June. As of June 15th, there was short interest totaling 1,500 shares, a drop of 16.7% from the previous total of 1,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

1.00% of iShares Neuroscience and Healthcare ETF's shares are currently sold short. Here is how the short interest of companies compare to iShares Neuroscience and Healthcare ETF: Global X Disruptive Materials ETF (1.50%), First Trust Nasdaq Lux Digital Health Solutions ETF (0.27%), iShares Breakthrough Environmental Solutions ETF (0.25%), AdvisorShares Restaurant ETF (0.58%), Amplify Weight Loss Drug & Treatment ETF (5.38%), ProShares Decline of the Retail Store ETF (0.32%), KraneShares 90% KWEB Defined Outcome Through January 2026 ETF (0.48%), Direxion Daily Travel & Vacation Bull 2X Shares (1.57%), Horizon Kinetics Energy and Remediation ETF (1.28%), Xtrackers US Green Infrastructure Select Equity ETF (0.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

Short selling IBRN is an investing strategy that aims to generate trading profit from iShares Neuroscience and Healthcare ETF as its price is falling. IBRN shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares Neuroscience and Healthcare ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IBRN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IBRN, twice per month. The most recent reporting period available is June, 15 2025.